This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iwen, P. C. Articles by Linder, J. Search for Related Content PubMed PubMed Citation Articles by Iwen, P. C. Articles by Linder, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Oct 1995, 2587-2591, Vol 33, No. 10
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens

PC Iwen, RA Walker, KL Warren, DM Kelly, SH Hinrichs and J Linder
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, USA.

A nucleic acid-based test (Gen-Probe PACE 2C System) was evaluated for the ability to detect Chlamydia trachomatis and Neisseria gonorrhoeae from endocervical specimens in a single assay. Three swab samples, randomized for collection order, were obtained from each patient and tested by N. gonorrhoeae and C. trachomatis culture and by the PACE 2C probe assay. Fifty of 395 specimens were culture positive for N. gonorrhoeae (17 specimens), C. trachomatis (26 specimens), or both (7 specimens), of which PACE 2C testing detected 48 specimens. The PACE 2C assay was positive for 56 specimens, including 8 specimens not positive by culture. Of the total of 10 discrepancies between culture and PACE 2C results, resolution testing yielded four false-negative culture, four false-positive PACE 2C, and two false-negative PACE 2C results. The sensitivity, specificity, and positive and negative predictive values for PACE 2C after reevaluation were 96.3, 98.8, 92.9 and 99.4%, respectively. The overall sensitivities for C. trachomatis and N. gonorrhoeae culture were 89.2 and 88.9%, respectively. The prevalence rate for C. trachomatis was 9.4%, and that for N. gonorrhoeae was 6.8%. The Gen-Probe PACE 2C System is a reliable alternative for screening endocervical specimens for both C. trachomatis and N. gonorrhoeae in a single assay.

This article has been cited by other articles:

• Lauderdale, T.-L., Landers, L., Thorneycroft, I., Chapin, K. (1999). Comparison of the PACE 2 Assay, Two Amplification Assays, and Clearview EIA for Detection of Chlamydia trachomatis in Female Endocervical and Urine Specimens. J. Clin. Microbiol. 37: 2223-2229 [Abstract] [Full Text]  
• Kehl, S. C., Georgakas, K., Swain, G. R., Sedmak, G., Gradus, S., Singh, A., Foldy, S. (1998). Evaluation of the Abbott LCx Assay for Detection of Neisseria gonorrhoeae in Endocervical Swab Specimens from Females. J. Clin. Microbiol. 36: 3549-3551 [Abstract] [Full Text]